Navid Naghsh

482 citations
14 papers · 304 indexed · h-index 9
Topics
Curcumin's Biomedical Applications (2 papers)Adipokines, Inflammation, and Metabolic Diseases (2 papers)Vitamin C and Antioxidants Research (2 papers)
Partner nations
IranIndiaUnited States

In The Last Decade

Navid Naghsh

14 papers receiving 301 citations

Peers

Navid Naghsh
Comparison fields: 5 of 90
  • Molecular Biology 80
  • Pulmonary and Respiratory Medicine 70
  • Hematology 38
  • Physiology 35
  • Pharmacology 34
Replace Nashwa Barakat with:
Nashwa Barakat Egypt
Hongyan Zhang China
Katrin Fischhuber Austria
Nasrin Ghassemi-Barghi Iran
Mona G. Amer Egypt
Zhongyuan Tang China
Gülce Naz Yazıcı Türkiye
Feng Qi China
Xiaojuan Chen China
Navid Naghsh relative to Nashwa Barakat Egypt Nashwa Barakat's profile →
Citations per field
00.5×1.5×
Nashwa Barakat · 1×
Citations per year

Countries citing papers authored by Navid Naghsh

Since Specialization
Citations

This map shows the geographic impact of Navid Naghsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Navid Naghsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Navid Naghsh more than expected).

Fields of papers citing papers by Navid Naghsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Navid Naghsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Navid Naghsh. The network helps show where Navid Naghsh may publish in the future.

Co-authorship network of co-authors of Navid Naghsh

This figure shows the co-authorship network connecting the top 25 collaborators of Navid Naghsh. A scholar is included among the top collaborators of Navid Naghsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Navid Naghsh. Navid Naghsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 5
2 9
3 15
4 7
5 1
6 11
7 94
8 34
9 23
10 8
11 17
12 4
13 8
14 68

About Navid Naghsh

Navid Naghsh is a scholar working on Complementary and Manual Therapy, Molecular Medicine and Biochemistry, having authored 14 papers that have together received 304 indexed citations. Recurring topics across this work include Curcumin's Biomedical Applications (2 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers) and Vitamin C and Antioxidants Research (2 papers). The work is most often cited by research in Pharmacology (34 citations), Molecular Medicine (19 citations) and Hematology (38 citations). Navid Naghsh has collaborated with scholars based in Iran, India and United States. Frequent co-authors include Zeynab Kavyani, Vali Musazadeh, Narges Norouzkhani, Niloofar Deravi, Elham Moslemi, Parvin Dehghan, Seyed Mohammad Ali Mirazimi, Amirhossein Davoodvandi, Michael R. Hamblin and Mohsen Chamanara. Their work appears in journals such as Physics Letters A, Pharmacological Research and Biomedicine & Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026